Literature DB >> 12613661

Transgenic and knock-out mice for deciphering the roles of EGFR ligands.

R W C Wong1.   

Abstract

Generation of genetically engineered mice with either gain-of-function or loss-of-function mutations is the most popular technique for determining gene functions and the interrelationship between molecules in vivo. These models have provided a wealth of information about the developmental and physiological roles of oncogenes and growth factors. To date, transgenic techniques have been used extensively to study the functions of the epidermal growth factor (EGF) family. This review highlights some of the major recent findings pertinent to the EGF receptor (EGFR) and its ligands with special reference to elucidating how EGF and its related growth factors work together to regulate reproduction, growth and development. Finally, future investigations on ligand-ligand communications, EGFR and its ligands in neural stem cell research, and the mechanisms of EGFR signaling and trafficking in cells are also suggested.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12613661     DOI: 10.1007/s000180300007

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  23 in total

1.  Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13.

Authors:  Zuzana Tobiasova; Klaas H B van der Lingen; Lawrence Scahill; James F Leckman; Yan Zhang; Wookjin Chae; James T McCracken; Christopher J McDougle; Benedetto Vitiello; Elaine Tierney; Michael G Aman; L Eugene Arnold; Liliya Katsovich; Pieter J Hoekstra; Fred Volkmar; Alfred L M Bothwell; Ivana Kawikova
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-11-09       Impact factor: 2.576

2.  Cells with intense EGFR staining and a high nuclear to cytoplasmic ratio are specific for infiltrative glioma: a useful marker in neuropathological practice.

Authors:  Fanny Burel-Vandenbos; Laurent Turchi; Maxime Benchetrit; Eric Fontas; Zoe Pedeutour; Valérie Rigau; Fabien Almairac; Damien Ambrosetti; Jean-François Michiels; Thierry Virolle
Journal:  Neuro Oncol       Date:  2013-08-09       Impact factor: 12.300

3.  A novel nanobody-based target module for retargeting of T lymphocytes to EGFR-expressing cancer cells via the modular UniCAR platform.

Authors:  Susann Albert; Claudia Arndt; Anja Feldmann; Ralf Bergmann; Dominik Bachmann; Stefanie Koristka; Florian Ludwig; Pauline Ziller-Walter; Alexandra Kegler; Sebastian Gärtner; Marc Schmitz; Armin Ehninger; Marc Cartellieri; Gerhard Ehninger; Hans-Jürgen Pietzsch; Jens Pietzsch; Jörg Steinbach; Michael Bachmann
Journal:  Oncoimmunology       Date:  2017-02-06       Impact factor: 8.110

4.  A phase 1 study of ABT-806 in subjects with advanced solid tumors.

Authors:  James M Cleary; David A Reardon; Nilofer Azad; Leena Gandhi; Geoffrey I Shapiro; Jorge Chaves; Michelle Pedersen; Peter Ansell; William Ames; Hao Xiong; Wijith Munasinghe; Matt Dudley; Edward B Reilly; Kyle Holen; Rod Humerickhouse
Journal:  Invest New Drugs       Date:  2015-04-17       Impact factor: 3.850

Review 5.  Nexus of signaling and endocytosis in oncogenesis driven by non-small cell lung cancer-associated epidermal growth factor receptor mutants.

Authors:  Byung Min Chung; Eric Tom; Neha Zutshi; Timothy Alan Bielecki; Vimla Band; Hamid Band
Journal:  World J Clin Oncol       Date:  2014-12-10

6.  Vertebrate Lrig3-ErbB interactions occur in vitro but are unlikely to play a role in Lrig3-dependent inner ear morphogenesis.

Authors:  Victoria E Abraira; Takunori Satoh; Donna M Fekete; Lisa V Goodrich
Journal:  PLoS One       Date:  2010-02-01       Impact factor: 3.240

Review 7.  The role of metals in modulating metalloprotease activity in the AD brain.

Authors:  Gulay Filiz; Katherine A Price; Aphrodite Caragounis; Tai Du; Peter J Crouch; Anthony R White
Journal:  Eur Biophys J       Date:  2008-02-13       Impact factor: 1.733

8.  Activation of the epidermal growth factor receptor promotes lymphangiogenesis in the skin.

Authors:  Daniela Marino; Yvonne Angehrn; Sarah Klein; Sabrina Riccardi; Nadja Baenziger-Tobler; Vivianne I Otto; Mark Pittelkow; Michael Detmar
Journal:  J Dermatol Sci       Date:  2013-05-04       Impact factor: 4.563

9.  Prolidase directly binds and activates epidermal growth factor receptor and stimulates downstream signaling.

Authors:  Lu Yang; Yun Li; Yi Ding; Kyoung-Soo Choi; A Latif Kazim; Yuesheng Zhang
Journal:  J Biol Chem       Date:  2012-12-04       Impact factor: 5.157

10.  The c-Jun NH2-terminal kinase is essential for epidermal growth factor expression during epidermal morphogenesis.

Authors:  Claire R Weston; Anthony Wong; J Perry Hall; Mary E P Goad; Richard A Flavell; Roger J Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.